Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00193700 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Evaluation of Testosterone Gel (1%)
A Phase 1 study, sponsored by Solvay Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00193700: Completed Phase 1 study, sponsored by Solvay Pharmaceuticals.
NCT00193700 is a Phase 1 study that has completed, run by Solvay Pharmaceuticals. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00193700, a Phase 1 study, has completed, sponsored by Solvay Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Measure and evaluate the level of testosterone in blood, and determine the safety and tolerability following daily applications of testosterone gel. Subjects who complete this trial may participate in the extension part (UMD-01-080E).
Interventions
- DRUG Testosterone Gel (1%)
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-08 |
| Phase | Phase 1 |
What the finished NCT00193700 record still lists
NCT00193700 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Testosterone Gel (1%) is the first listed.
NCT00193700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00193700 about?
NCT00193700 is a clinical study titled "Pharmacokinetic Evaluation of Testosterone Gel (1%)". Measure and evaluate the level of testosterone in blood, and determine the safety and tolerability following daily applications of testosterone gel. Subjects who complete this trial may participate in the extension part (UMD-01-080E).
What is the current status of trial NCT00193700?
This trial is currently completed. It is a Phase 1 study. The study started on 2002-08.
What interventions are being tested in trial NCT00193700?
The interventions under investigation include: Testosterone Gel (1%) (DRUG).
Who is sponsoring clinical trial NCT00193700?
This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia